Arkolith/Insider Trading/DMK/Form 4

Versi Ebrahim

CEO, DirectorDMK PHARMACEUTICALS Corp (DMK) · full profile →Form 4 · filed Sep 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2023Conversion(C)729K—$0906K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 15, 2023Conversion(C)729—$01K

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001387131-23-011359) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML